Clinical Research Directory
Browse clinical research sites, groups, and studies.
Diagnosis of Sleep-Related Respiratory Disorders in Patients With Narcotic Medications
Sponsor: Kaiser Permanente
Summary
The present study is a prospective, single cohort study involving patients on narcotic medications, undergoing overnight sleep studies in the clinical sleep laboratory. The main hypothesis for the study is that the the frequency of sleep respiratory events (including central apneas) identified by a home sleep apnea test (HSAT) device (WatchPAT200U (wp200U) with centrals; Itamar Medical Ltd.) will significantly correlate with in-lab polysomnography (gold standard).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2019-08-08
Completion Date
2025-03-13
Last Updated
2026-07-20
Healthy Volunteers
Yes
Conditions
Interventions
WatchPAT 200
The WatchPAT200 device has been approved by the Food and Drug Administration (FDA) for testing sleep related disorders in patients ages 17 and older. They are widely used with thousands of studies performed in the United States to validate the devices accuracy and efficacy. It is also routinely used in many other countries. The devices are not currently being used for patients who are currently taking narcotic medications at Kaiser Permanente. Therefore, we are asking patients to simultaneously wear this device during an in-lab study, so we can test how effective and accurate the WatchPAT 200 is in diagnosing sleep breathing disorders in patients on narcotic medications.
Locations (1)
Sleep Center; San Bernardino County Medical Center, Kaiser Permanente
Fontana, California, United States